Matthias Hoffmann
53Patents
16h-index
122Co-inventors
87Inventor score
Filing activity: Apr 7, 1999 → Aug 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6806272B2 | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions | Chemistry; Metallurgy | 73 | Expired |
| US6861422B2 | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions | Chemistry; Metallurgy | 65 | Expired |
| US7241769B2 | Pyrimidines as PLK inhibitors | Chemistry; Metallurgy | 60 | Expired |
| US7371753B2 | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions | Human Necessities | 48 | Expired |
| US7241889B2 | 6-formyl-tetrahydropteridines, process for their manufacture and use thereof as medicaments | Human Necessities | 38 | Expired |
| US7332491B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 33 | Expired |
| US8003786B2 | Dihydropteridinone compounds | Chemistry; Metallurgy | 30 | Active |
| US7414053B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 27 | Expired |
| US7625899B2 | Pyridodihydropyraziones, process for their manufacture and use thereof as medicaments | Human Necessities | 25 | Active |
| US7629460B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 25 | Active |
| US7759347B2 | 2-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments | Human Necessities | 21 | Active |
| US7700769B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 20 | Active |
| US7728134B2 | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | Chemistry; Metallurgy | 19 | Expired |
| US7786299B2 | Methods for treating diseases or conditions using dihydropteridinone compounds | Chemistry; Metallurgy | 19 | Expired |
| US7723517B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 19 | Active |
| US7807831B2 | Dihydropteridione derivatives, process for their manufacture and their use as medicament | Emerging Cross-Sectional Technologies | 19 | Active |
| US8278302B2 | Substituted piperidines as CCR3 antagonists | Chemistry; Metallurgy | 13 | Active |
| US8653075B2 | Therapeutic methods employing substituted piperidines which are CCR3 antagonists | Chemistry; Metallurgy | 13 | Active |
| US6187780A | Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity | Chemistry; Metallurgy | 11 | Expired |
| US8034816B2 | Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | Chemistry; Metallurgy | 9 | Active |
| US8193188B2 | Methods of using pyridodihydropyrazinones | Human Necessities | 8 | Active |
| US8202867B2 | Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide | Chemistry; Metallurgy | 8 | Active |
| US7132104B1 | Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders | Human Necessities | 7 | Expired |
| US6492377B1 | Imidazotriazolopyrimidines with adenosine-antagonistic activity | Chemistry; Metallurgy | 7 | Expired |
| US8604049B2 | 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.